Authored By: Sarah
26 Jun 2024

 Needle-Free Injection Systems Market Size to grow by USD 15375.4 million between 2023-2027

According to a research report “ Needle-Free Injection Systems Market” by End-user (Hospitals and clinics, Home care settings, Research laboratories) Product (Fillable, Pre-filled) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2027 published by Technavio, the market size is estimated to grow by USD 15375.4 million, at a CAGR of  15.06% during the forecast period. In the healthcare industry, biopsy procedures are instrumental in the early detection and diagnosis of various types of cancer, including bone cancer. These diagnostic methods are essential for healthcare professionals to accurately assess the health status of individuals suspected of having cancer. Fine-needle aspiration cytology (FNAC) biopsy, core needle biopsy, image-guided biopsy, and surgical biopsy are commonly used biopsy techniques. While these procedures offer accurate results, they come with invasive complications such as bruising, swelling, bleeding, and infections. The needle-free injection systems market presents an opportunity to mitigate these complications by offering non-invasive alternatives for biopsy procedures, enhancing patient comfort and safety.

Browse market data tables, figures, and in-depth TOC on “Needle-Free Injection Systems Market” by End-user (Hospitals and clinics, Home care settings, Research laboratories) Product (Fillable, Pre-filled) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2027. Download Free Sample


By End-user, the Hospitals and clinics segment is projected to dominate the market size in 2024

In the needle-free injection systems market, fillable systems offer advantages such as ease of storage as they are not pre-filled with drugs. Instead, these systems fill the drug from separate vials or ampoules. This convenience is driving demand in the segment. However, the precise dosage and convenience offered by pre-filled needle-free injection systems are expected to boost their demand, leading to a slight decline in the growth rate of the fillable segment. Nevertheless, the increasing preference for painless administration of injections will propel the expansion of the global needle-free injection systems market during the forecast period.

By Product, Fillable  segment is expected to hold the largest market size for the year 2024

In the healthcare industry, hospitals and clinics dominate the global needle-free injection systems market. These systems are widely utilized in hospitals for the administration of vaccines, anticoagulants, biologics, and pharmaceutical drugs. The preference for needle-free injection drug delivery among healthcare professionals is on the rise due to its advantages, including ease of use and precise dosing. In contrast to conventional needles and syringes, needle-free injection systems are increasingly favored by professionals for their convenience and efficiency. Clinics and private healthcare facilities, which cater to outpatients, prioritize the delivery of diagnostic, therapeutic, or preventive healthcare treatments. The adoption of needle-free injection systems in these settings is a testament to their growing acceptance and value in modern healthcare.

North America is forecasted to hold the largest market size by region in 2024

The Needle-Free Injection Systems market is predominantly driven by the US market, which leads the regional landscape due to several factors. These include extensive insurance coverage and reimbursements, substantial R&D expenditure, a growing geriatric population with chronic diseases, increasing incidences of needlestick injuries (NSIs), rising demand for self-administered drugs, and significant healthcare spending. According to NCBI data, approximately six million NSIs occur annually in the US. The market's growth in the US is further propelled by the adoption of needle-free systems with safety features and the presence of advanced medical facilities. Notably, states such as Indiana, Ohio, and Illinois are anticipated to witness robust growth due to the increasing number of accredited diagnostic laboratories.

The Needle-Free Injection Systems Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Aijex Pharma International Inc.
  • Amico Group
  • Antares Pharma Inc.
  • Becton Dickinson and Co.
  • Endo International Plc
  • Ferring BV
  • Inovio Pharmaceuticals Inc.
  • Lepu Medical Technology Beijing Co. Ltd.
  • Medbitz Pte Ltd.
  • Mika Medical Co.
  • NuGen Medical Devices
  • Technologies Médicales Internationales Inc.
  • West Pharmaceutical Services Inc.
  • Crossject
  • Needle Free Injection System
  • PharmaJet Inc.
  • Recipharm AB

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Needle-Free Injection Systems Market encompasses innovative technologies that deliver medications, including insulin and vaccines, without the use of traditional needles. These systems are gaining popularity in various sectors such as Oncology, where they offer a more comfortable experience for cancer patients. In the field of Insulin Delivery, needle-free systems are being explored for their potential to improve patient compliance and reduce the risk of needlestick injuries. Vibration-based, laser-powered, and jet-based needle-free systems are some of the advanced technologies in this market. Research laboratories, home care, hospitals, and clinics are key end-users of these systems. Intradermal, intramuscular, and subcutaneous injectors are the main types of needle-free systems, catering to different application areas. Powder-based and liquid-based injectors are two primary categories of needle-free systems. Microarray patches are another emerging technology in this market, particularly for vaccine delivery. Biologics, communicable diseases, mass vaccination, geriatric population, and chronic diseases are some of the significant applications for needle-free injection systems. The market's growth is driven by factors like the need to reduce needlestick injuries, the increasing prevalence of chronic diseases, and the demand for self-injection devices.

Market Research Overview

The Needle-Free Injection Systems Market encompasses a range of innovative technologies that offer painless drug delivery in various settings, including home care and hospitals. These systems include vibration-based, laser-powered, and jet-based needles, which eliminate the need for traditional needles for intradermal and subcutaneous injections. Prefilled and fillable syringes are also part of this market, used in home care settings for insulin delivery, vaccine administration, and pain management. Hospitals and clinics benefit from needle-free systems in oncology, where patients often require frequent injections. Research laboratories use these systems for handling large molecule drugs and biologics, reducing the risk of needlestick injuries and communicable diseases. Home care settings, telecare, AI, IT, and e-prescription are also adopting needle-free systems for self-injection devices. Microarray patches are another type of needle-free injectors, used for vaccine delivery and chronic disease management. Sterility, IT integration, and compatibility with HIV/AIDS and infectious diseases are essential considerations for this market. The geriatric population and self-administration of drugs are driving the growth of this market. The need for painless drug delivery, especially in mass vaccination campaigns, is another significant factor.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!